Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial (opens in new tab) 5 articles covering this post

investor.lilly.com··r/longevity·Covered by scientificamerican.com + 4 more·Open original

redditTags: <a href="

Read the original article

Sign in to keep reading the full article.

Cited by 5 articles

Next-gen weightloss drug retatrutide trial shows users lose almost a third of their body weight

scientificamerican.com

·

Retatrutide hits 28% weight loss in Phase 3

chamath.substack.com··Substack

Retatrutide's phase 3 results: 30% weight loss in 2 years

empirical.health··Hacker News